| Market Cap | 799M 699M 645M 595M 1.13B 76.19B 1.15B 7.7B 3.02B 37.54B 3B 2.93B 129B | P/E 2023 |
2,007x | P/E 2024 | -3.42x |
|---|---|---|---|---|---|
| Enterprise Value | 964M 843M 778M 719M 1.36B 91.96B 1.39B 9.3B 3.65B 45.3B 3.62B 3.54B 156B | EV / Sales 2023 |
8.58x | EV / Sales 2024 | 4.64x |
| Free-Float |
98.58% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 day | -2.83% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2025-09-14 | |
Richard McAvoy
DFI | Director of Finance/CFO | - | 2026-05-31 |
David Stewart
CTO | Chief Tech/Sci/R&D Officer | - | 2025-10-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.83% | +7.69% | - | - | 799M | |
| -0.51% | +1.57% | +17.05% | -7.30% | 67.61B | |
| -5.16% | -8.63% | +38.70% | +203.59% | 51.6B | |
| +5.28% | +39.50% | +39.50% | +39.50% | 43B | |
| -2.10% | +0.89% | -48.99% | -53.63% | 40.94B | |
| +0.12% | -7.85% | +48.39% | -28.83% | 29.4B | |
| -10.83% | -14.41% | +102.94% | -44.10% | 27.09B | |
| -1.53% | -0.13% | +70.16% | +85.73% | 23.32B | |
| +3.88% | +2.16% | +11.36% | +192.66% | 19.92B | |
| -1.59% | -1.63% | +64.87% | +130.98% | 16.91B | |
| Average | -1.53% | -3.02% | +38.22% | +57.62% | 35.53B | |
| Weighted average by Cap. | -1.36% | -2.83% | +31.31% | +48.54% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 149M 131M 120M 111M 211M 14.24B 215M 1.44B 565M 7.01B 560M 548M 24.11B | 140M 122M 113M 104M 198M 13.34B 201M 1.35B 530M 6.57B 525M 514M 22.6B |
| Net income | 560K 490K 452K 417K 792K 53.41M 805K 5.4M 2.12M 26.31M 2.1M 2.06M 90.45M | -141M -123M -114M -105M -199M -13.42B -202M -1.36B -533M -6.61B -528M -517M -22.73B |
| Net Debt | 151M 132M 122M 113M 214M 14.42B 217M 1.46B 572M 7.11B 568M 555M 24.43B | 165M 145M 133M 123M 234M 15.77B 238M 1.59B 626M 7.77B 621M 607M 26.7B |
Employees
-
Sector
Pharmaceuticals
Choose MarketScreener 
